0001681622 false 0001681622 2020-02-13 2020-02-14 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): February 14, 2020

 

 

 

VAREX IMAGING CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

Delaware

(State or Other Jurisdiction of Incorporation)

 

001-37860 81-3434516
(Commission File Number)

(IRS Employer
Identification No.)

 

1678 S. Pioneer Road, Salt Lake City, Utah 84104
(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code: (801972-5000

 

Not Applicable

(Former name or former address, if changed since last report)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock VREX The Nasdaq Global Select Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b - 2 of the Securities Exchange Act of 1934. Emerging growth company ¨  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨  

 

 

 

 

 

 

Item 5.02.Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

(e)

 

On February 11, 2020, Varex Imaging Corporation (the “Company”) announced that its Senior Vice President and Chief Financial Officer, Clarence R. Verhoef, plans to retire in 2020.

 

In connection with his retirement and transition from Chief Financial Officer, on February 11, 2020, the Compensation and Management Development Committee of the Board of Directors of the Company approved the following compensation arrangement for Mr. Verhoef in his role as a non-executive employee of the Company, to be effective as of the date a successor has been appointed (the “Transition Date”):

 

·For a period of up to 12 months following the Transition Date, base salary of approximately $394,000 per year, continued health benefits, and continued vesting of equity grants received prior to the Transition Date.
   
·For a further period of up to 12 months, base salary of $60,000 per year and continued vesting of equity grants received prior to the Transition Date.

 

In addition, on February 13, 2019, at the 2020 Annual Meeting of Stockholders (the “Annual Meeting”) of the Company, the Company’s stockholders approved the Varex Imaging Corporation 2020 Omnibus Stock Plan (the “2020 Stock Plan”).

 

A summary of the 2020 Stock Plan is set forth in the proxy statement on Schedule 14A filed on January 2, 2020 (the “Proxy Statement”). That summary and the foregoing description are qualified in their entirety by reference to the text of the 2020 Stock Plan, which is filed as Exhibit 10.1 to this report and is incorporated herein by reference.

 

Item 5.07Submission of Matters to a Vote of Security Holders

 

The final results for the votes of the Annual Meeting regarding each proposal voted on at the Annual Meeting are set forth in the following tables. Each of these proposals is described in detail in the Proxy Statement.

 

Proposal One:

 

The Company’s stockholders elected Jocelyn D. Chertoff, Ruediger Naumann-Etienne, and Sunny S. Sanyal to serve as directors until the 2022 Annual Meeting of Stockholders:

   For  Withheld Authority  Abstain  Broker Non-Votes
Jocelyn D. Chertoff  33,273,953   246,545  67,493  2,490,501
Ruediger Naumann-Etienne  33,222,705   297,516  67,770  2,490,501
Sunny S. Sanyal  33,420,763   99,575  67,653  2,490,501

 

 

 

 

Proposal Two:

 

The Company’s stockholders approved, on an advisory basis, the compensation of the Company’s executive officers as disclosed in the Proxy Statement:

 

For  Against  Abstain  Broker Non-Votes
31,419,007  2,105,150  63,834  2,490,501

 

Proposal Three:

 

The Company’s stockholders approved the 2020 Stock Plan:

 

For  Against  Abstain  Broker Non-Votes
25,142,323  8,375,100  70,568  2,490,501

 

Proposal Four:

 

The Company’s stockholders ratified the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year 2020:

 

For  Against  Abstain
35,718,240  304,203  56,049

 

  Item 9.01. Financial Statements and Exhibits

 

  (d) Exhibits

 

Exhibit Number   Description
10.1   Varex Imaging Corporation 2020 Omnibus Stock Plan and related forms of award agreements
104  

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    VAREX IMAGING CORPORATION    
   
     
Dated: February 14, 2020 By: /s/ Kimberley E. Honeysett
    Kimberley E. Honeysett
    Senior Vice President, General Counsel and Corporate Secretary